Seven patients with advanced mitral valve disease and systemic pulmonary hypertension subjected to mitral valve replacement without survival are presented here with the common denominator or the characteristic additional finding of aneurysmal dilatation of the pulmonary artery. During the same period 16 other patients with similar degree of valvular dysfunction and systemic pulmonary hypertension underwent mitral valve replacement with nearly 50 percent of them surviving the operation. The only major diflerence between the two groups was the presence of pulmonary artery aneurysm in the former group with uniformly fatal termination. It is suggested that this roentgenographic sign "under the circumstances outlinedn indicates extremely grave prognosis for mitral valve replacement, and, therefore, consideration should be given to either no operative treatment or closed mitral commissurotomy if at all feasible.
neurysm of the pulmonary artery (Fig 1 and 2 ) A was the common denominator in seven patients who died shortly after mitral valve replacement for long-standing mitral valve disease associated with systemic pulmonary hypertension (Table 1) . To determine the prognostic value of this roentgenographic sign the records of all patients subjected to isolated mitral valve replacement (nearly 250) and in particular those presenting with similar degree of valvular dysfunction and systemic pressure in the pulmonary artery (16 patients, Table 2 ) were reviewed. The latter group were clinically and hemodynamically similar to the seven patients under consideration except for the absence of pulmonary artery aneurysm and, therefore, constituted the control group. The study which indicated the unfavorable prognostic value of aneurysmal dilatation of the pulmonary artery in these patients is summarized in this report. There were no other patients with pulmonary artery aneurysms subjected to mitral valve replacement in the entire series. Three other patients with this sign and systemic pulmonary hypertension, however, had undergone closed mitral commissurotomy and are included in the discussion. The group with pulmonary artery aneurysm consisted of seven patients, all women but one, their ages ranging from 30 to 85 years with a mean age of 52 years. According to the New York Heart Association classification five were Class IV and two were Class 111 at the time of surgery. All had suffered one or more episodes of congestive heart failure in spite of cardiac drugs and diuretics. Four patients had moderate tricuspid insufficiency and one had moderate aortic insufficiency. Mitral valve was predominantly stenotic in five and purely stenotic in two patients. The valve was calcified in five patients. Four patients gave a history of rheumatic fever and in the remaining three, there was no question as to the rheumatic origin of their valvular disease. Peripheral embolization had occurred in two and three other patients had had deep venous thrombosis with only two having had proved pulmonary infarction. The electrocardiogram showed atrial fibrillation in all, right ventricular hypertrophy in six and biventricular hypertrophy in one patient. Chest roentgenograms showed the usual characteriqtics of long-standing mitral valve disease-cardiomegaly, left atrial enlargement, congested lung fields and prominent Kerley-B lines. The most impressive and exceptional feature of the x-ray films which differed from those presenting with identical clinical and he~nodynamic findings was the extraordinary dilatation or aneurysm of the pulmonary artery (Fig 1 and 2 ). Cardiac catheterization in all patients showed low cardiac output, moderate to marked mitral stenosis and systemic pulmonary hypertension. The pulmonary artery pressure ranged from 98 to 140 mm Hg, while the aortic pressure ranged from 106 to 149 mm Hg. Pulmonary artery pressure exceeded aortic pressure in one, nearly equaled or was in excess of 90 percent of aortic pressure in the remaining patients. The pulmonary arteriolar resistance was extremely high, ranging from 1,100 dynes/sec/cm-5 to 2,890 dynes/sec/cm-5 (Table 1 ) . FIGURE 1 (upper) and 2 (lower): Chest roentgenograms of two patients (54-year-old man and a 65-year-old woman) with mitral valve disease and systemic pulmonary hypertension. Arrows point to the extremely large or aneurysmal pulmonary arteries.
All patients were subjected to mitral valve replacement with a Start-Edwards prosthesis. Three patients had left atrial thrombectomy. The very impressive operative finding was aneurysmal dilatation of the pulmonary artery. This vessel appeared nearly three times larger than the aorta in every patient. The rest of the operative findings were similar to those seen in all patients with advanced mitral valve disease and significant pulmonary hypertension. The operation was uncmmplicated in all patients. One patient died on the operating table, five died within seven days and one seven weeks after surgery. The cause in all patients was intractable congestive heart failure, particularly failure of the right ventricle. The postoperative course was characterized by low cardiac output, edema, hepatomegaly, severe oliguria, desaturation, intractable nletabolic acidosis and poor peripheral perfusion. Autopsy performed in all revealed cardiomegaly, left atrial enlargement, right ventricular hypertrophy and multiple pulmonary complications. These consisted of --pulmonary edema, chronic passive pulmonary congestion, extensive interstitial fibrosis and in the majority disseminated bronchopneumonitis. One patient had evidence of both chronic and acute pulmonary infarction. The valves were in proper position in all patients. Again, the unusual autopsy finding was the size of the pulmonary artery. The main pulmonary artery measured 5.6 to nearly 7 cm in diameter while the aorta measured less than 3 cm in these patients. Microscopic examination of the lungs showed chronic and acute pulmonary congestion, hemosiderin-laden macrophages, disseminated fibrotic and inflammatory processes and, in particular, moderate degree of arteriosclerosis. The control group without aneurysmal dilatation of the pulmonary artery was comprised of 16 patients, four men and 12 women, 31 to 68 years of age with a mean of 50 years. According to the New York Heart Association classification, ten were Class IV and six were Class 111 at the time of surgery. All but one had previously been admitted to the hospital for congestive heart failure. Additional valvular heart disease in this group consisted of moderate to severe tricuspid insufficiency in eight patients and some degree of aortic valve disease, predominantly aortic insufficiency, in four patients. In the majority the predominant hemodynamic abnormality was mitral stenosis. All patients were in atrial fibrillation and elechocardiogram showed either right or biventricular hypertrophy in every instance. Chest roentgenograms showed severe cardiomegaly, left atrial enlargement, congested lung fields and prominent Kerley-B lines. In this group, the main pulmonary artery showed some enlargement, but was not aneurysmal. This observation constituted the only major difference in the two groups. Cardiac catheterization performed in all of these patients showed low cardiac output, and moderate to marked m i h d stenosis in all but two patients who had pure mihal insufficiency. In addition these patients were categorized to have systemic pulmonary hypertension.
PULMONARY ARTERY ANEURYSM
The pulmonary artery pressure in this group ranged from 89 to 154 mm Hg while the aortic pressure ranged from 81 to 135 mm Hg. Pulmonary artery pressures exceeded aortic pressure in four, and it was in excess of 90 percent of aortic pressure in 12 patients. Similarly the pulmonary arteriolar resi~tance was exceedingly high ranging from 897 dynes/sec/cm-5 to 2,000 dynes/sec/cm-5. Although the pulmonary arteriolar resistance was somewhat lower in this group, the pulmonary systemic resistance ratios were comparable in the two groups. There were nine patients in this group with pulmonary arteriolar resistance exceeding 1,100 dynes/sec/cm-5 of whom seven survived surgery. Mikal valve replacement with a Starr-Edwards prosthesis was performed in every patient in this group. Five patients had left atrial thrombi which were removed and in four patients additional operative procedures were performed to corrcSct the incompetent aortic or bicuspid valve or both. The pillmonary artery, although somewhat larger than normal ill every instance, did not show aneurysmal dilatation. Thrtv patient.; died in the operating room and five died within 12 days after surgery, representing a hospital mortality of .so percent. Of the eight patienb discharged fmm the hospit;~l. one died 2% months postoperation and seven were long-tt-rm survivors. It was most interesting to note that three of the, survivors who are continuing to do well had pulmonary artery pressure in excess of the aortic pressure prior to surgery.
Among the factors influencing the operative mortality of mitral valve replacement, the degree of pulmonary hypertension is considered of great significance. In a previous review we1 reported 16 percent mortality in patients with mild to moderate pulmonary hypertension while the risk increased to 61 percent in the presence of systemic pressure in the pulmonary artery. Several years ago after the second patient with mitral stenosis and systemic pulmonary hypertension died following replacement of mitral valve and was known to have had aneurysmal dilatation of the pulmonary artery, I
became interested in correlating this sign with the results of mitral valve replacement under these circumstances. Within the next few years five additional patients with aneurysmal dilatation of the pulmonary artery and advanced mitral valve disease associated with systemic pulmonary hypertension followed the same fatal course after surgery. There were no other patients with pulmonary artery aneurysm in the entire series of nearly 250 patients. There were 23 patients who had systemic pressure in the pulmonary artery with pulmonary arteriolar resistance in the majority exceeding 1,000 dynes/ sect cm-5. Seven of these with pulmonary artery aneurysm comprise the group under consideration and the remaining 16 patients without pulmonary artery aneurysm constitute the control group. While the first group suffered 100 percent mortality, nearly 50 percent of the control group survived surgery. This indicates a definitely higher risk of mitral valve replacement in the presence of pulmonary artery aneurysm in the special group of patients with long-standing mitral valve disease and systemic pulmonary hypertension. It should be stressed that in comparing the two groups the only major difference was the presence of aneurysmal dilatation of the pulmonary artery in the seven patients under consideration terminating uniformly fatal. Further review of our experience showed that three other patients with aneurysmal dilatation of the pulmonary artery and systemic pulmonary hypertension had survived closed mitral commissurotomy. It would appear that tremendous dilatation of the pulmonary artery to the extent that one can conveniently use the term aneurysm "in the presence of systemic pulmonary hypertension" represents a grave prognostic sign and in all probability a fatal outcome if the mitral valve is replaced under these circun~stances. Since the majority of these patients had predominantly severe mitral stenosis, one may have achieved some palliation from closed mitral commissurotomy. The pathogenesis of such degree of pulmonary artery dilatation can probably be explained on the basis of nondistensible peripheral pulmonary vasculature, therefore making available to the hypertrophied right ventricular thrust during systole only the proximal pulmonary arterial tree to receive stroke volume. The pulmonary artery, highly resistant to atherosclerotic changes, undergoes significant systolic expansion to receive the blood during systole. Indirectly this indicates the lack of elasticity and compliance of the peripheral pulmonary vasculature caused by largely irreversible arteriolar sclerosis. Patients with systemic pulmonary hypertension will survive mitral valve replacement if at the completion of surgery the right heart strain is at least partially relieved. If no improvement in obstruction to the pulmonary arterial flow is obtained it is unlikely the patient will survive mitral valve replacement which necessitates the use of extracorporeal circulation with its inherent hemodynamic abnormalities.*-4 Based on clinical impression derived from this study, caution is advised in recommending mitral valve replacement under these circumstances. Undoubtedly the same degree of pulmonary artery dilatation on a different basis and not associated with systemic pulmonary hypertension would not bear similar grave prognosis. It should also be emphasized that some degree of pulmonary artery dilatation is always present in patients with mitral valve disease and systemic pulmonary hypertension.
In the seven patients presented here, however, the enlargement of the pulmonary artery far exceeded the usual degree of dilatation one is accustomed to seeing. REFERENCES
